Clinical trial
A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone…
NCT00134173 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00134173 |
|---|---|
| Title | A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease |
| Official title | Phase 3, Multi-Center, Double-Blind, Randomized, Parallel Group, Coronary Artery Intravascular Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With… |
| Acronym | ILLUSTRATE |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Disease, Coronary Arteriosclerosis, Hyperlipidemia |
| Intervention type | Drug |
| Interventions | torcetrapib/atorvastatin, atorvastatin |
| Enrollment | 1,100 |
| Start date | Oct 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Aug 24, 2005 |
| Last update posted | Dec 10, 2007 |
| Countries | Belgium, Canada, Netherlands, Poland, Spain, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: